CheckMyRecalls

Cardinal Health Inc. recalls Wegovy (semaglutide) injection

Published
7 May 2025
Units affected
48 Cartons
Agency
FDA
Country
United States

The hazard

Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.

Brand / company
Cardinal Health Inc.
Codes / lots
Lot PZFDE06, Exp 08/31/2025
Distribution
NC, SC, VA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.